Structure Optimization of 12β-<em>O</em>-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy
The farnesoid X receptor (FXR) plays a crucial role in regulating the metabolism of bile acids, lipids, and sugars. Consequently, it is implicated in the treatment of various diseases, including cholestasis, diabetes, hyperlipidemia, and cancer. The advancement of novel FXR modulators holds immense...
Main Authors: | Hao Ma, Yunyang Bao, Shuaishuai Niu, Shaorong Wang, Yiming Li, Hongwei He, Na Zhang, Weishuo Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/5/758 |
Similar Items
-
Discovery of Farnesoid X Receptor Antagonists Based on a Library of Oleanolic Acid 3-O-Esters through Diverse Substituent Design and Molecular Docking Methods
by: Shao-Rong Wang, et al.
Published: (2017-04-01) -
Design and Synthesis of a Dual Linker for Solid Phase Synthesis of Oleanolic Acid Derivatives
by: Shaorong Wang, et al.
Published: (2011-06-01) -
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
by: An-Na Moon, et al.
Published: (2024-04-01) -
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model
by: Philipp Schwabl, et al.
Published: (2021-01-01) -
Hybrid Compounds Strategy in the Synthesis of Oleanolic Acid Skeleton-NSAID Derivatives
by: Anna Pawełczyk, et al.
Published: (2016-04-01)